Related Experiment Video

Updated: Aug 17, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Cdk2 dethroned as master of S phase entry

Philip W Hinds1

  • 1Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. phil_hinds@hms.harvard.edu

Cancer Cell
|May 3, 2003
PubMed

Insights

Cyclin-dependent kinase 2 (cdk2) is not essential for cancer cell proliferation, challenging its role as a therapeutic target. Tumor cells lacking cdk2 protein and activity show no impairment in growth.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Cancer research

Background:

  • Cyclin-dependent kinase 2 (cdk2) has been widely considered a key regulator of cell cycle progression.
  • cdk2 is also viewed as a promising therapeutic target for cancer treatment due to its role in cell proliferation.

Purpose of the Study:

  • To investigate the necessity of cdk2 protein and its kinase activity for tumor cell proliferation.
  • To challenge the prevailing view of cdk2 as an indispensable target in cancer therapy.

Main Methods:

  • Analysis of tumor cells with genetic deficiencies in cdk2.
  • Assessment of cell proliferation rates in cdk2-deficient versus wild-type cancer cells.
  • Evaluation of cdk2 protein expression and kinase activity.

Main Results:

  • Tumor cells lacking cdk2 protein and kinase activity were observed.
  • These cdk2-deficient tumor cells did not exhibit impaired proliferation.
  • Proliferation rates were comparable to cells with functional cdk2.

Conclusions:

  • The role of cdk2 in regulating cancer cell proliferation may be less critical than previously assumed.
  • The therapeutic targeting of cdk2 in cancer may require re-evaluation.
  • Alternative or complementary therapeutic strategies might be necessary for cancers reliant on other cell cycle regulators.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...